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ABSTRACT
Background. Depression is highly co-morbid with both psychiatric and chronic somatic disease.
These types of co-morbidity have been shown to exert opposite eﬀects on underdiagnosis of de-
pression by general practitioners (GPs). However, past research has not addressed their combined
eﬀect on underdiagnosis of depression.
Method. Co-morbidity data on 191 depressed primary-care patients selected by a two-stage
sampling procedure were analysed. Diagnoses of major depression and/or dysthymia in the last
12 months were assessed using a standardized psychiatric interview (CIDI) and compared with
depression diagnoses registered by GPs in patient contacts during the same period. Presence of
psychiatric and chronic somatic co-morbidity was determined using the CIDI and contact regis-
tration, respectively.
Results. Regression analysis showed a signiﬁcant interaction eﬀect between psychiatric and chronic
somatic co-morbidity on GPs’ diagnosis of depression, while taking into account the eﬀects of
sociodemographic variables, depression severity and number of GP contacts. Subsequent stratiﬁed
analysis revealed that in patients without chronic somatic co-morbidity, a lower educational level, a
less severe depression, and fewer GP contacts all signiﬁcantly increased the likelihood of not being
diagnosed as depressed. In contrast, in patients with chronic somatic co-morbidity, only having no
psychiatric co-morbidity signiﬁcantly decreased the likelihood of receiving a depression diagnosis.
Conclusions. Our results indicate that the eﬀects of psychiatric co-morbidity and other factors on
underdiagnosis of depression by GPs diﬀer between depressed patients with and without chronic
somatic co-morbidity. Eﬀorts to improve depression diagnosis by GPs seem to require diﬀerent
strategies for depressed patients with and without chronic somatic co-morbidity.
INTRODUCTION
Major depressive disorder (MDD) is a common
disorder associated with signiﬁcant disability,
poorer quality of life, increased morbidity and
mortality, and increased use of health services
(Cassano & Fava, 2002; Papakostas et al.
2004). MDD does not occur frequently in pure
form, but is often co-morbid with other psychi-
atric disorders, in particular anxiety disorders
(Kessler et al. 1996; Ravelli et al. 1998), and a
wide range of long-term medical conditions, in-
cluding endocrine, neurological, cardiac, diges-
tive, and respiratory disorders, cancer, diabetes
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mellitus, arthritis, hypertension, and acquired
immunodeﬁciency syndrome (Moldin et al. 1993;
Wittchen et al. 1999; Gagnon & Patten, 2002).
Most depressive disorders are managed ex-
clusively by general practitioners (GPs) (Ormel
& Tiemens, 1997). However, despite being one
of the most prevalent disorders in primary care
(Cassano & Fava, 2002), depression is poorly
recognized and diagnosed by GPs, with most
studies reporting a rate of underdiagnosis fall-
ing in the 60–70% range (Bensing & Verhaak,
1994; Docherty, 1997). Although the clinical
signiﬁcance of this underdiagnosis has been
disputed (Ormel & Tiemens, 1997), several lines
of research underline that it is worthwhile
trying to improve the diagnosis of depression in
primary care. First, a substantial proportion
of undetected depressed patients have persist-
ently poor outcomes over the course of one
year (Goldberg et al. 1998; Rost et al. 1998).
Secondly, there is evidence for the eﬃcacy of
both pharmacological and psychotherapeutic
interventions for the treatment of MDD in pri-
mary care (Mulrow et al. 2000; Schulberg et al.
2002). The third and most important piece of
evidence is provided by recent systematic re-
views of primary-care trials, which have con-
cluded that, compared with usual care, quality
improvement eﬀorts aimed at improving detec-
tion of depression can improve patients’ out-
comes provided that those recognized receive
adequate treatment and follow-up (Pignone
et al. 2002; Bijl et al. 2004). To improve the de-
tection rate of depression by GPs, it is important
to have detailed knowledge about the barriers to
the diagnosis of depression. In this respect the
impact of the frequent presence of co-morbidity
on underdiagnosis of depression should be more
thoroughly examined.
Previous studies have shown that patients
with MDD have a higher risk of being not di-
agnosed as depressed by GPs if they have ad-
ditional somatic illness(es) (Freeling et al. 1985;
Coulehan et al. 1990; Tylee et al. 1993, 1995;
Sartorius et al. 1996). In contrast, the co-occur-
rence of MDD and anxiety has been found to
facilitate recognition of depression (Coyne et al.
1995) or psychiatric caseness (Ormel et al. 1990;
Sartorius et al. 1996; Pini et al. 1997, 1999).
However, these studies examined the eﬀects of
psychiatric and somatic co-morbidity on under-
diagnosis of depression separately, and did
not address their combined eﬀect at all. Because
a substantial proportion of depressed primary-
care patients are expected to have both somatic
as well as psychiatric co-morbidity (Wittchen
et al. 1999; Maier & Falkai, 1999) it is important
to examine their combined eﬀect, in particular
in the context of their suggested opposite
eﬀects on underdiagnosis of depression. The
current study examines, therefore, whether there
is an interaction eﬀect between psychiatric and
chronic somatic co-morbidity on GPs’ diagnosis
of depression, while accounting for the eﬀects
of factors that are frequently reported to be
associated with depression diagnosis (i.e. socio-
demographic factors, severity of depression, and
number of contacts with GP). If so, then the
eﬀects of psychiatric co-morbidity and the other
factors will be studied in subgroups of depressed
patients with and without chronic somatic co-
morbidity. The results could lead to a more
precise identiﬁcation of barriers to the diag-
nosis of depression and thereby contribute to
improved quality of GP care and outcomes of
MDD in primary care.
METHOD
Study setting
Data collection took place within the frame-
work of the second Dutch National Survey of
General Practice (2001; DNSGP-2) (Westert
et al. 2005), a nationwide study of morbidity
and interventions in general practice in The
Netherlands. The DNSGP-2 was carried out in
104 practices comprising 195 GPs, who served
approximately 390 000 persons. The partici-
pating GPs were representative of all GPs in The
Netherlands regarding age, gender, region of
residence and urbanization. Dutch GPs are gate-
keepers for secondary health care and nearly
all non-institutionalized persons are listed to
a GP. Three datasets were used, that is data
from (a) a health interview survey, (b) a stan-
dardized psychiatric interview, and (c) a contact
registration.
Participants
A random sample of the practice population
(n=12 699) participated in an extensive health
interview survey (response rate=64.5%),
spread over a whole year to avoid seasonal
patterns. In total 1379 patients aged 18 and
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older had an indication of psychopathology
as measured by two screening instruments
included in the health interview (see below).
These patients were approached for follow-up
psychiatric assessment using the Composite
International Diagnostic Interview (CIDI)
(WHO, 1997), and 58.8% (n=811) were actually
assessed. CIDI data on 235 patients were not
examined in this study because : (1) the data
were either incomplete (n=11) or obtained by
using erroneously an earlier version of the CIDI
(n=6); (2) patients were diagnosed by their
GP as either having dementia (n=2) or a
psychotic illness (n=2) and presence of these
disorders was not assessed using the CIDI;
(3) patients had no contact with their GP within
the time frame covered by the CIDI (n=214).
The remaining 576 patients did not diﬀer sig-
niﬁcantly from the eligible patients who were
not examined (n=803) regarding age, edu-
cational level, and scores on the 12-item General
Health Questionnaire (GHQ-12), and CAGE
questionnaire, though a higher proportion was
female ( p<0.01). Of the 576 patients those who
fulﬁlled the DSM-IV criteria for MDD and/or
dysthymia according to CIDI (n=191) were
included in the ﬁnal study population.
Measures
The Dutch version of the GHQ-12 was ad-
ministered as a screener for non-psychotic psy-
chiatric morbidity (Koeter & Ormel, 1991).
Scores of o4 (ﬁrst half of 2001) oro3 (second
half of 2001) were used as thresholds for follow-
up psychiatric assessment. The cut-oﬀ score was
lowered to enlarge the group of eligible patients.
A three/four threshold has a high sensitivity
(84.6%) and speciﬁcity (89.3%) in a primary-
care setting (Goldberg et al. 1997). Additionally,
the Dutch version of the CAGE questionnaire
was used to identify patients with alcohol
problems (Ewing, 1984). The maximum score of
four positive answers was used as a threshold
for further psychiatric assessment. Although
this criterion is highly speciﬁc for detecting
alcohol abuse/dependence in primary-care pa-
tients, it has a low sensitivity (23%; Aertgeerts
et al. 2004). However, since this study examined
patients with MDD who were already detected
by the highly sensitive GHQ-12, falsely low
prevalence rates of alcohol-related disorders due
to this low sensitivity were avoided.
The CIDI is a fully structured interview that
allows administration by trained lay interview-
ers. The Dutch version of the computerized
CIDI-auto 2.1 was used (Ter Smitten et al.
1998). The fully speciﬁed structure does not al-
low judgement of the interviewer to intervene.
Standardized probe questions establish that
psychiatric symptoms are clinically signiﬁcant
and not due to medication, drugs or alcohol, or
to a physical illness or injury. After completion
of the interview, computerized algorithms pro-
vide diagnoses according to the DSM-IV. The
presence of the following psychiatric disorders
in the past 12 months was determined: phobic
and other anxiety disorders, depressive dis-
orders and dysthymic disorder, manic and bi-
polar aﬀective disorder, and disorders resulting
from the use of alcohol. During the interview,
respondents are asked about the ﬁrst and last
occurrence of psychiatric symptoms, on the
basis of which the period during which a
psychiatric disorder was present was estimated
for each patient.
During one year, all GPs electronically re-
corded each diagnosis made during their con-
tacts with a patient, coded according to the
International Classiﬁcation of Primary Care
(ICPC) (Lamberts & Wood, 1987). Contacts
belonging to the same health problem were
clustered into disease episodes.
Deﬁnitions
DSM-IV diagnoses obtained from the CIDI
were considered as the reference standard.
Patients were regarded as depressed in case of a
diagnosis of MDD and/or dysthymia (hereafter
referred to as ‘depressed patients ’). For all
patients the diagnosis was considered positive
when all diagnostic criteria (inclusion as well as
exclusion criteria) were fulﬁlled, with the ex-
ception of two patients with dysthymic disorder
for whom only inclusion criteria were met.
A GP diagnosis of depression could be
coded under depression (ICPC code P76), which
is based on the criteria of the International
Classiﬁcation of Health Problems in Primary
Care (WONCA, 1983). These criteria are largely
consistent with those of DSM-IV for MDD. In
addition, depressive symptoms could also be
coded under depressive feelings (ICPC code
P03). Therefore, patients having an episode P76
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and/or P03 were considered to be diagnosed as
depressed by their GP, while patients without
such episodes were not.
The presence of psychiatric co-morbidity was
determined on the basis of the CIDI data and
was deﬁned as having at least one CIDI diag-
nosis other than MDD/dysthymia. Psychiatric
co-morbidity had to be present during at least
one GP–patient contact. The following three
categories of psychiatric co-morbidity were
formed: alcohol abuse/dependence, bipolar dis-
order, and anxiety disorder, including the ﬁve
subcategories panicdisorder, agoraphobia (with-
out panic), social phobia, generalized anxiety
disorder (GAD), and simple phobia.
The presence of chronic somatic co-morbidity
was determined on the basis of ICPC-coded di-
agnoses of chronic conditions recorded by GPs
and deﬁned as having at least one episode of
chronic disease. It was ascertained that chronic
somatic co-morbidity was present during the
period of MDD and/or dysthymia. The follow-
ing eight categories of chronic somatic co-
morbidity were created, based on the body
systems involved: neurological conditions (mi-
graine or regular serious headache, dizziness,
Parkinson’s disease, multiple sclerosis, epi-
lepsy) ; musculoskeletal conditions (chronic
rheumatism, rheumatic complaints of hips and
knees, serious or persistent neck/shoulder, back,
and hands/elbow/wrist disorder) ; circulatory
conditions (hypertension, vascular disorder,
myocardial infarction, other serious heart dis-
orders, stroke); respiratory conditions (asthma/
chronic bronchitis or chronic nonspeciﬁc lung
disease) ; skin conditions (chronic eczema, pso-
riasis) ; endocrine, metabolic, and nutritional
conditions (diabetes mellitus, hyperthyroidism,
hypothyroidism); digestive conditions (serious
disorders of the intestine longer than three
months, e.g. Crohn’s disease) ; and a rest categ-
ory (incontinence, cancer, HIV infection, glau-
coma).
Other explanatory variables included socio-
demographic and clinical variables which fre-
quently have been found to be associated with
GPs’ diagnosis of depression (Docherty, 1997;
Tylee, 1999). Sociodemographic data (age, gen-
der, highest educational level attained) were
derived from the health interview survey.
Educational level was categorized into three
classes: low (none, elementary school), middle
(high school), and high (college or university).
Severity of depression was derived from the
CIDI and was operationalized as the number of
depressive symptoms with scores ranging from 5
to 9 (DSM-IV criterion A for MDD). Patients
who had a diagnosis of dysthymia alone (n=7)
were given a score of four on this measure.
Annual number of GP–patient contacts was
categorized by quartiles, which resulted in the
categories 1–3, 4–6, 7–10, ando11 contacts.
Statistical analyses
Rates of GPs’ depression diagnosis in sub-
groups of depressed patients based on co-
morbidity characteristics were calculated to
explore the relationship between co-morbidity
status and depression diagnosis. In a second
explorative analysis, the bivariate relationships
between co-morbidity, sociodemographic (age,
gender, educational level) and clinical (de-
pression severity and GP contact rate) variables
and depression diagnosis were examined using
simple logistic regression analyses. Next, multi-
variate logistic regression analysis was con-
ducted in three steps. The ﬁrst model entered
psychiatric co-morbidity and chronic somatic
co-morbidity. In addition to the co-morbidity
variables, model 2 entered the sociodemo-
graphic and clinical variables. The ﬁnal multi-
variate model included model 1 and 2 variables,
plus the interaction term between psychiatric
and chronic somatic co-morbidity. In case of a
signiﬁcant interaction eﬀect, separate multi-
variate analyses were carried out in patient
subgroups stratiﬁed by presence or absence of
chronic somatic co-morbidity.
Additional regression analyses were per-
formed to explore the eﬀects of the number of
co-morbidities (categorized into three categ-
ories : 0, 1, and o2) and the speciﬁc co-morbid
disease categories. Also, a number of sup-
plementary analyses were performed to test the
robustness of the multivariate logistic regression
results. First, several studies have reported an
association between depression severity and
psychiatric co-morbidity, in particular anxiety
co-morbidity (e.g. Roy-Byrne et al. 2000). To
examine a possible collinearity eﬀect between
these variables multivariate regression analyses
were repeated without the variable depression
severity. Secondly, to examine whether the
possible inclusion of unexplained symptoms
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aﬀected the results, analyses were repeated after
excluding patients with symptom diagnosis only
and no somatic disease diagnosis. Thirdly, to
test whether lowering the GHQ-12 cut-oﬀ score
inﬂuenced the results, analyses were repeated
including a dummy variable GHQ threshold.
Finally, all analyses were repeated in multi-
level models to examine whether the results
were aﬀected by variations among the general
practices.
Analyses were conducted using SPSS version
11.0 for Windows, except for the multilevel
analyses, which were performed using the
MLwiN software version 1.1. Signiﬁcance was
accepted at the 5% level.
RESULTS
Study population characteristics and depression
diagnosis rates
Table 1 illustrates the characteristics of the 191
depressed patients. According to the CIDI, 157
patients had MDD alone, seven had dysthymia
alone, and 27 had both MDD and dysthymia.
Psychiatric co-morbidity was present in just
over half of the depressed patients, about the
same prevalence rate as chronic somatic co-
morbidity. Anxiety disorder was by far the most
common co-morbid psychiatric disorder, with
GAD being the most frequent speciﬁc anxiety
disorder; the most prevalent co-morbid chronic
somatic disease category was musculoskeletal,
followed by the circulatory and neurological
categories. About a quarter of the patients had
both psychiatric and chronic somatic disease in
addition to their depression, while two-ﬁfths
had no co-morbidity.
As shown in Table 2, 55 of the 191 depressed
patients were diagnosed as depressed by GPs
(ICPC code P76: n=41; ICPC code P03: n=11;
both codes : n=3), while 136 depressed patients
were not diagnosed, resulting in an overall rate
of underdiagnosis of 71.2%.
Table 1. Characteristics of the depressed
patients (percentages unless stated otherwise)
Total group (n=191)








Mean depression severity (S.D.) 6.6 (1.2)







Chronic somatic co-morbidity 51.8
Psychiatric and somatic co-morbidity 25.7








Categories of psychiatric co-morbidity
Anxiety disorder 49.2
Alcohol abuse/ dependence 7.9
Bipolar disorder 1.0









Table 2. Rate of general practitioners’ diag-
nosis of depression in subgroups of depressed




All depressed patients (n=191) 28.8







Patients with chronic somatic
co-morbidity (n=99)
26.3
Patients without chronic somatic
co-morbidity (n=92)
31.5
Subgroups stratiﬁed by chronic
somatic co-morbidity
Patients without chronic somatic
co-morbidity and:
(a) with psychiatric co-morbidity (n=53) 34.0
(b) without psychiatric co-morbidity (n=39) 28.2
Patients with chronic somatic co-morbidity and
(a) with psychiatric co-morbidity (n=49) 36.7
(b) without psychiatric co-morbidity (n=50) 16.0
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Interestingly, the depression diagnosis rates
in patient subgroups based on co-morbidity
characteristics suggest a possible interaction ef-
fect between psychiatric and chronic somatic co-
morbidity on depression diagnosis. That is, the
diﬀerence in depression diagnosis rate between
depressed patients with psychiatric co-morbidity
and those without psychiatric co-morbidity
was small in the subgroup of patients with-
out chronic somatic co-morbidity, as compared
with the substantial diﬀerence observed in the
subgroup of patients with chronic somatic co-
morbidity.
Logistic regression results
As shown in Table 3, bivariate analyses revealed
that having no psychiatric co-morbidity, having
fewer contacts with a GP, and being less severely
depressed all signiﬁcantly increased the risk of
underdiagnosis of depression. The multivariate
results are also presented in Table 3. Shown are
the main eﬀects of psychiatric and chronic
somatic co-morbidity on depression diagnosis
when considered jointly in the same model
(model 1) and when all other explanatory vari-
ables were entered (model 2). As a last step, the
interaction between the two co-morbidity types
was entered. Importantly, this ﬁnal multivariate
model showed a signiﬁcant interaction eﬀect
between psychiatric and chronic somatic co-
morbidity on depression diagnosis. Subsequent
stratiﬁed analysis (see Table 4) revealed that
psychiatric co-morbidity had no signiﬁcant ef-
fect on depression diagnosis in patients without
chronic somatic co-morbidity. Having a lower
educational level, having a lower annual num-
ber of GP contacts and having a less severe
level of depression all signiﬁcantly increased the
risk of underdiagnosis of depression in this pa-
tient subgroup. In contrast, in patients with
chronic somatic co-morbidity, psychiatric co-
morbidity was signiﬁcantly associated with de-
pression diagnosis : depressed patients with
chronic somatic co-morbidity but no psychiatric
co-morbidity were more likely to receive no
depression diagnosis than those with both
psychiatric and chronic somatic co-morbidity.
None of the other variables was signiﬁcantly
associated with depression diagnosis in this
patient subgroup.
Additional multivariate analyses: number and
category of co-morbidities
The number of psychiatric co-morbidities
exerted no signiﬁcant eﬀect in patients without
chronic somatic co-morbidity, whereas among
patients with chronic somatic co-morbidity a
lower number of psychiatric co-morbidities
Table 3. Results of bivariate and multivariate logistic regression analysis for general practitioners’










Psychiatric co-morbidityc 2.01 (1.05–3.85)* 1.98 (1.03–3.80)* 1.32 (0.63–2.76) 0.55 (0.19–1.58)
Chronic somatic co-morbidityd 0.77 (0.41–1.45) 0.81 (0.43–1.54) 0.65 (0.30–1.42) 0.24 (0.07–0.78)*
Psychiatricrchronic somatic co-morbidity 5.32 (1.23–22.98)*
Age 0.99 (0.97–1.02) 0.99 (0.97–1.02) 0.99 (0.96–1.02)
Gendere 0.81 (0.41–1.60) 0.56 (0.25–1.22) 0.57 (0.26–1.27)
Educational level 1.31 (0.88–1.94) 1.72 (1.07–2.77)* 1.84 (1.13–2.98)*
Annual number of GP contacts 1.41 (1.08–1.86)* 2.13 (1.44–3.18)** 2.34 (1.54–3.54)**
Depression severity 1.71 (1.24–2.35)** 1.34 (0.99–1.82) 1.39 (1.02–1.90)*
Nagelkerke R-square 0.037 0.19 0.23
OR, Odds ratio; CI, conﬁdence interval.
*p<0.05, **p<0.001.
a Includes all other explanatory variables.
b Also includes interaction of psychiatric and chronic somatic co-morbidity.
c Reference group for psychiatric co-morbidity: those without psychiatric co-morbidity.
d Reference group for chronic somatic co-morbidity : those without chronic somatic co-morbidity.
e Reference group for gender: males.
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decreased the likelihood of receiving a de-
pression diagnosis (OR 2.40, 95% CI 1.26–4.59,
p<0.01). Again, signiﬁcant eﬀects of education,
number of GP contacts, and depression severity
were conﬁned to patients without chronic
somatic co-morbidity. Regarding speciﬁc co-
morbidity categories, patients with a co-morbid
musculoskeletal condition but no co-morbid
GAD were more likely to receive no depression
diagnosis than patients with both a co-morbid
musculoskeletal condition and a co-morbid
GAD (OR 6.17, 95% CI 1.39–27.41, p<0.05).
In contrast, in patients without a co-morbid
musculoskeletal condition no eﬀect of co-mor-
bid GAD was found. Again, only in these latter
patients signiﬁcant eﬀects were present for edu-
cation, contact rate and depression severity. The
eﬀects of other speciﬁc categories were not ana-
lysed, because patient numbers were too small
for meaningful analysis.
Additional multivariate analyses: robustness of
ﬁndings
Supplementary multivariate analyses underlined
the robustness of the ﬁndings. That is, a model
excluding depression severity, a model taking
into account lowering of the GHQ-12 threshold,
and a model allowing for the variation among
practices, all yielded basically identical results.
Exclusion of the 17 patients who were diagnosed
only with (possible unexplained) symptoms
revealed also essentially the same results, except
that the eﬀect of psychiatric co-morbidity on
depression diagnosis was no longer signiﬁcant
among the patients with chronic somatic
co-morbidity (OR 2.64, 95% CI 0.92–7.54,
p<0.10).
DISCUSSION
About half of our sample of patients who had
depression as assessed according to the CIDI
had either co-morbid psychiatric or co-morbid
chronic somatic disease. Nearly a quarter of the
depressed patients exhibited both types of co-
morbidity, and this high rate underlines the
importance of studying the impact of having
both chronic somatic as well as psychiatric co-
morbidity on underdiagnosis of depression by
GPs. Previous studies examined the eﬀects of
psychiatric and somatic co-morbidity only sep-
arately. Our study elaborated on the past
research and showed that there is an interaction
eﬀect between psychiatric and chronic somatic
co-morbidity on depression diagnosis. Only in
depressed patients with a co-morbid chronic
somatic condition did having no psychiatric co-
morbidity increase the risk of being not diag-
nosed as depressed. Furthermore, none of the
other factors under study were found to exert
signiﬁcant eﬀects in this subgroup of patients,
while in those without chronic somatic co-
morbidity, a lower educational level, a lower
annual number of GP contacts and a less severe
level of depression all increased the likelihood of
being not diagnosed as depressed.
It should be noted that the eﬀect of psychi-
atric co-morbidity in patients with chronic so-
matic co-morbidity was no longer signiﬁcant
after excluding patients with only symptom
Table 4. Results of logistic regression analysis for general practitioners ’ depression diagnosis in
depressed patients stratiﬁed by presence or absence of chronic somatic co-morbidity
No chronic somatic co-morbidity
(n=92) OR (95% CI)
Chronic somatic co-morbidity
(n=99) OR (95% CI)
Psychiatric co-morbiditya 0.33 (0.093–1.18) 2.99 (1.06–8.39)*
Age 0.98 (0.94–1.03) 0.99 (0.95–1.03)
Genderb 0.32 (0.088–1.15) 0.70 (0.24–2.11)
Educational level 3.04 (1.23–7.24)* 1.39 (0.73–2.63)
Annual number of GP contacts 3.80 (1.92–7.53)** 1.72 (0.95–3.11)
Depression severity 1.88 (1.15–3.07)* 1.13 (0.72–1.76)
Nagelkerke R-square 0.36 0.16
OR, odds ratio; CI, conﬁdence interval.
*p<0.05, ** p<0.001.
a Reference group for psychiatric co-morbidity : those without psychiatric co-morbidity.
b Reference group for gender: males.
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diagnoses. Further research is needed to deter-
mine whether this was caused by reduced stat-
istical power or whether it indicates that the
signiﬁcant psychiatric co-morbidity eﬀect in our
total group of patients with chronic somatic co-
morbidity is a coincidental ﬁnding. A possible
explanation for a facilitating eﬀect of psychi-
atric co-morbidity on depression diagnosis is
that GPs may be better able to detect a mental
problem in chronically medically ill patients
when non-depressive psychiatric symptoms,
that is, symptoms more speciﬁc to anxiety and/
or alcohol-related disorders, are also present.
This higher detection rate might result in an
increased likelihood of diagnosing depression,
because GPs are probably better acquainted
with depression than other psychiatric disorders
encountered in primary care and will, therefore,
interpret any mental distress as indications of
depression (Sartorius et al. 1996). Another
possible explanation is that a speciﬁc co-
morbidity pattern accounted for the facilitating
eﬀect on diagnosing depression in patients
with concomitant chronic somatic disease.
Explorative analysis suggested that having a
co-morbid GAD facilitated depression diag-
nosis in patients with a co-morbid musculoskel-
etal condition. However, the eﬀects of other
speciﬁc co-morbidity patterns remained unclear,
because too few cases precluded meaningful
analysis.
The higher annual GP contact rate among
depressed patients with chronic somatic co-
morbidity compared with those with no
concomitant chronic somatic condition could
explain the diﬀerential eﬀect of contact rate in
the two subgroups. Because almost all
depressed, chronically somatically ill patients
already had contact with their GP on a regular
basis (i.e. o4 contacts: 92%; o7 contacts :
64%), it is probable that a higher frequency of
contact will not have much inﬂuence on diag-
nosing depression. In contrast, a substantial
number of depressed patients without somatic
co-morbidity consulted their GP only once or a
few times during the last year (i.e.f3 contacts :
32%; 1–2 contacts : 22%). Accordingly, GPs
have little opportunity to recognize depressive
symptoms in these patients, and the likelihood
of depression diagnosis will be increased in
the non-chronically ill patients with a higher
contact rate.
One could question the clinical relevance of
the ﬁnding that less severe depression decreased
the likelihood of receiving a depression diag-
nosis in patients with no chronic somatic co-
morbidity. Diagnosis may not be needed in
all patients with relatively mild forms of
depression, because quite a large number of
these patients seem to recover spontaneously
without being detected as depressed (Simon &
VonKorﬀ, 1995; Simon et al. 1999). On the
other hand, it has been indicated that a sub-
stantial number of undetected depressed
primary-care patients have persistently poor
outcomes over the course of one year (Goldberg
et al. 1998; Rost et al. 1998). Of concern is that a
more severe level of depression did not facilitate
diagnosis among patients with chronic somatic
co-morbidity, particularly in the context that
most of these patients had regular contact with
their GPs. It is of special importance to diagnose
major depression in chronically medically ill
patients, because its presence has been demon-
strated to lead to ampliﬁcation of chronic
medical illness symptoms, additive functional
impairment, and poorer self-care and adher-
ence (Whooley & Simon, 2000; Katon &
Ciechanowski, 2002). Also, depression co-
morbid with chronic somatic disease may have
poorer course and outcome than depression
without co-morbidity (Maier & Falkai, 1999;
Wittchen et al. 1999). For these reasons, it is
widely advocated that major depression must
be appropriately and aggressively treated in
patients with chronic somatic disease (Sutor
et al. 1998; Whooley & Simon, 2000; Cassano &
Fava, 2002). Indeed, appropriate treatment has
been found to improve both the course and
outcome of depression and the co-morbid
somatic disease as well as patient quality of life
(Maier & Falkai, 1999; Koike et al. 2002;
Stockton et al. 2004).
It should be kept in mind that the discussed
results were obtained by using a multivariate
model that included both psychiatric co-
morbidity and depression severity. In the vast
majority of cases psychiatric co-morbidity
implied co-morbid anxiety disorder(s), with
GAD being the most prevalent speciﬁc co-
morbid anxiety disorder. As anxiety disorders in
general, and GAD particularly, share several
common symptoms with MDD, one might
question whether anxiety co-morbidity and
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depression severity are distinct. Indeed, some
researchers view them not as distinct entities,
but rather conceptualize anxiety-depression co-
morbidity as an indicator of severity of psycho-
pathology (Preisig et al. 2001; Angst et al. 2002;
Schoevers et al. 2003). However, we consider
anxiety co-morbidity and depression severity as
related but distinct constructs. This position was
based on reviews of research on the most com-
mon anxiety-depression co-morbidity, that is,
MDD–GAD co-morbidity, which argue against
the view that GAD should be conceptualized as
a severity marker for MDD rather than as an
independent disorder (Kessler, 2000; Kessler
et al. 2001). Several lines of evidence point to this
conclusion, including reports that the symptoms
of GAD form an empiric cluster distinct from
the symptoms of major depression. Viewing
psychiatric co-morbidity and depression severity
as distinct entities is supported by the ﬁnding
that the eﬀects of psychiatric co-morbidity on
depression diagnosis remained essentially the
same after dropping depression severity from
the multivariate model. If psychiatric co-
morbidity and depression severity were indis-
tinguishable entities, one would expect the
model excluding depression severity to show a
signiﬁcant eﬀect of psychiatric co-morbidity on
depression diagnosis among depressed patients
without chronic somatic co-morbidity, which
was not the case. Anyhow, further longitudinal
research is needed to disentangle the concepts
of psychiatric co-morbidity and depression
severity and their relationship with depression
diagnosis.
Some limitations of our study must be noted.
First, the generalizability of the ﬁndings might
be restricted by the relatively high attrition rate.
The signiﬁcant diﬀerence between participant
and non-participants regarding gender seemed
to be of no major inﬂuence given that gender
consistently did not exert a signiﬁcant eﬀect in
our analyses. However, it cannot be ruled out
that other diﬀerences between participants and
non-participants could have aﬀected the
ﬁndings. Secondly, not all sections of the CIDI
were administered, which may have confounded
assessment of psychiatric co-morbidity. For
instance, the assessment of somatoform dis-
orders was lacking, which are known to be
common in primary care and co-morbid with
depression (Maier & Falkai, 1999). Finally, only
small numbers of patients had certain speciﬁc
diseases, which precluded meaningful analysis
of the eﬀects of speciﬁc (combinations of )
psychiatric and chronic somatic co-morbidity
categories.
In conclusion, the results of our study indicate
that the factors that are associated with under-
diagnosis of depression by GPs are diﬀerent
for depressed patients without chronic somatic
co-morbidity in comparison with depressed
patients with chronic somatic co-morbidity.
This implies that eﬀorts to improve GPs’ diag-
nosis of depression require diﬀerent approaches
for depressed patients with and without co-
morbid somatic illness. Our results suggest that
GPs need to be more alert to symptoms of
depression in the less well-educated, non-
chronically somatically ill patients. The aware-
ness of (the importance to diagnose and treat)
depression in chronically somatically ill patients
should be raised among GPs. Educating GPs in
overcoming the diagnostic challenge of diﬀer-
entiating depressive symptomatology from co-
morbid chronic somatic disease and/or to refer
chronically somatically ill patients to mental
health specialists if they suspect a depression
could increase the quality of care for these
patients.
ACKNOWLEDGEMENTS
This study has been supported by a grant from
ZonMw, The Netherlands Organization for
Health Research and Development (CZ-TT
2001). The authors would also like to thank





Aertgeerts, B., Buntinx, F. & Kester, A. (2004). The value of the
CAGE in screening for alcohol abuse and alcohol dependence in
general clinical populations : a diagnostic meta-analysis. Journal of
Clinical Epidemiology 57, 30–39.
Angst, J., Sellaro, R. & Merikangas, K. R. (2002). Multimorbidity of
psychiatric disorders as an indicator of clinical severity. European
Archives of Psychiatry and Clinical Neuroscience 252, 147–154.
Bensing, J. M. & Verhaak, P. F. (1994). Mental problems in family
practice more variable and diﬀuse than in psychiatry. Nederlands
Tijdschrift voor de Geneeskunde 138, 130–135.
Diagnosing depression and co-morbidity 1193
Bijl, D., Van Marwijk, H. W. J., De Haan, M., Van Tilburg, W. &
Beekman, A.-J. T. F. (2004). Eﬀectiveness of disease management
programmes for recognition, diagnosis and treatment of de-
pression in primary care. European Journal of General Practice 10,
6–12.
Cassano, P. & Fava, M. (2002). Depression and public health : an
overview. Journal of Psychosomatic Research 53, 849–857.
Coulehan, J. L., Schulberg, H. C., Block, M. R., Janosky, J. E. &
Arena, V. C. (1990). Medical comorbidity of major depressive
disorder in a primary medical practice. Archives of Internal
Medicine 150, 2363–2367.
Coyne, J. C., Schwenk, T. L. & Fechner-Bates, S. (1995).
Nondetection of depression by primary care physicians recon-
sidered. General Hospital Psychiatry 17, 3–12.
Docherty, J. P. (1997). Barriers to the diagnosis of depression in
primary care. Journal of Clinical Psychiatry 58 (Suppl. 1), 5–10.
Ewing, J. A. (1984). Detecting alcoholism. The CAGE questionnaire.
Journal of the American Medical Association 252, 1905–1907.
Freeling, P., Rao, B. M., Paykel, E. S., Sireling, L. I. & Burton, R. H.
(1985). Unrecognised depression in general practice. British
Medical Journal 290, 1880–1883.
Gagnon, L. M. & Patten, S. B. (2002). Major depression and its
association with long-term medical conditions. Canadian Journal
of Psychiatry 47, 149–152.
Goldberg, D. P., Gater, R., Sartorius, N., Ustun, T. B., Piccinelli, M.,
Gureje, O. & Rutter, C. (1997). The validity of two versions of the
GHQ in the WHO study of mental illness in general health care.
Psychological Medicine 27, 191–197.
Goldberg, D., Privett, M., Ustun, B., Simon, G. & Linden, M. (1998).
The eﬀects of detection and treatment on the outcome of major
depression in primary care: a naturalistic study in 15 cities. British
Journal of General Practice 48, 1840–1844.
Katon, W. & Ciechanowski, P. (2002). Impact of major depression on
chronic medical illness. Journal of Psychosomatic Research 53,
859–863.
Kessler, R. C. (2000). The epidemiology of pure and comorbid gen-
eralized anxiety disorder : a review and evaluation of recent
research. Acta Psychiatrica Scandinavica 102 (Suppl. 406), 7–13.
Kessler, R. C., Keller, M. B. & Wittchen, H. U. (2001). The epidemi-
ology of generalized anxiety disorder. Psychiatric Clinics of North
America 24, 19–39.
Kessler, R. C., Nelson, C. B., McGonagle, K. A., Liu, J., Swartz, M.
& Blazer, D. G. (1996). Comorbidity of DSM-III-R major de-
pressive disorder in the general population: results from the US
National Comorbidity Survey. British Journal of Psychiatry 168
(Suppl. 30), 17–30.
Koeter, M. W. & Ormel, J. (1991). General Health Questionnaire:
Dutch adaptation. Swets and Zeitlinger : Lisse.
Koike, A. K., Unu¨tzer, J. & Wells, K. B. (2002). Improving the care
for depression in patients with comorbid medical illness. American
Journal of Psychiatry 159, 1738–1745.
Lamberts, H. & Wood, W. (1987). International Classiﬁcation of
Primary Care (ICPC). Oxford University Press: Oxford.
Maier, W. & Falkai, P. (1999). The epidemiology of comorbidity
between depression, anxiety disorders and somatic diseases.
International Clinical Psychopharmacology 14 (Suppl. 2), S1–S6.
Moldin, S. O., Scheftner, W. A., Rice, J. P., Nelson, E., Knesevich,
M. A. & Akiskal, H. (1993). Association between major
depressive disorder and physical illness. Psychological Medicine
23, 755–761.
Mulrow, C. D., Williams, J. W., Chiquette, E., Aguilar, C.,
Hitchcock-Noel, P., Lee, S., Cornell, J. & Stamm, K. (2000).
Eﬃcacy of newer medications for treating depression in primary
care patients. American Journal of Medicine 108, 54–64.
Ormel, J. & Tiemens, B. (1997). Depression in primary care. In
Depression: Neurobiological, Psychopathological and Therapeutic
Advances. Wiley Series on Clinical and Neurobiological Advances in
Psychiatry, Vol. 3 (ed. A. Honig and H. M. van Praag), pp.
83–108. John Wiley & Sons: New York.
Ormel, J., Van den Brink, W., Koeter, M. W., Giel, R., Van der Meer,
K., Van de Willige, G. & Wilmink, F. W. (1990). Recognition,
management and outcome of psychological disorders in primary
care: a naturalistic follow-up study. Psychological Medicine 20,
909–923.
Papakostas, G. I., Petersen, T., Mahal, Y., Mischoulon, D.,
Nierenberg, A. A. & Fava, M. (2004). Quality of life assessments
in major depressive disorder: a review of the literature. General
Hospital Psychiatry 26, 13–17.
Pignone, M. P., Gaynes, B. N., Rushton, J. L., Burchell, C. M.,
Orleans, C. T., Mulrow, C. D. & Lohr, K. N. (2002). Screening for
depression in adults : a summary of the evidence for the U.S.
Preventive Services Task Force. Annals of Internal Medicine 136,
760–764.
Pini, S., Berardi, D., Rucci, P., Piccinelli, M., Neri, C., Tansella, M.
& Ferrari, G. (1997). Identiﬁcation of psychiatric distress
by primary care physicians. General Hospital Psychiatry 19,
411–418.
Pini, S., Perkonnig, A., Tansella, M., Wittchen, H. U. & Psich, D.
(1999). Prevalence and 12-month outcome of threshold and sub-
threshold mental disorders in primary care. Journal of Aﬀective
Disorders 56, 37–48.
Preisig, M., Merikangas, K. R. & Angst, J. (2001). Clinical signiﬁ-
cance and comorbidity of subthreshold depression and anxiety in
the community. Acta Psychiatrica Scandinavica 104, 96–103.
Ravelli, A., Bijl, R. V. & Van Zessen, G. (1998). Comorbidity of
psychiatric disorders in the Dutch population: results of the
Netherlands Mental Health Survey and Incidence Study
(NEMESIS). Tijdschrift voor Psychiatrie 40, 531–544.
Rost, K., Zhang, M., Fortney, J., Smith, J., Coyne, J. & Smith Jr., R.
(1998). Persistently poor outcomes of undetected major depression
in primary care. General Hospital Psychiatry 20, 12–20.
Roy-Byrne, P. P., Stang, P., Wittchen, H. U., Ustun, B., Walters,
E. E. & Kessler, R. C. (2000). Lifetime panic-depression co-
morbidity in the National Comorbidity Survey. British Journal of
Psychiatry 176, 229–235.
Sartorius, N., Ustun, T. B., Lecrubier, Y. & Wittchen, H. U. (1996).
Depression comorbid with anxiety: results from the WHO study
on psychological disorders in primary health care. British Journal
of Psychiatry 168 (Suppl. 30), 38–43.
Schoevers, R. A., Beekman, A. T. F., Deeg, D. J. H., Jonker, C.
& Van Tilburg, W. (2003). Comorbidity and risk-patterns of
depression, generalised anxiety disorder and mixed anxiety-
depression in later life : results from the AMSTEL study.
International Journal of Geriatric Psychiatry 18, 994–1001.
Schulberg, H. C., Raue, P. J. & Rollman, B. L. (2002). The eﬀective-
ness of psychotherapy in treating depressive disorders in primary
care practice : clinical and cost perspectives. General Hospital
Psychiatry 24, 203–212.
Simon, G. E., Goldberg, D., Tiemens, B. G. & Ustun, T. B. (1999).
Outcomes of recognized and unrecognized depression in an inter-
national primary care study. General Hospital Psychiatry 21,
97–105.
Simon, G. E. & VonKorﬀ, M. (1995). Recognition, management, and
outcomes of depression in primary care. Archives of Family
Medicine 4, 99–105.
Stockton, P., Gonzales, J. J., Stern, N. P. & Epstein, S. A. (2004).
Treatment patterns and outcomes of depressed medically ill and
non-medically ill patients in community psychiatric practice.
General Hospital Psychiatry 26, 2–8.
Sutor, B., Rummans, T. A., Jowsey, S. G., Krahn, L. E., Martin,
M. J., OConnor, M. K., Philbrick, K. L. & Richardson, J. W.
(1998). Major depression in medically ill patients. Mayo Clinic
Proceedings 73, 329–337.
Ter Smitten, M. H., Smeets, R. M. W. & Van den Brink, W. (1998).
Composite International Diagnostic Interview – Computerised
version 2.1: Dutch translation and adaptation. WHO–CIDI
Training en Referentie Centrum, Psychiatrisch Centrum AMC:
Amsterdam.
Tylee, A. (1999). Depression in the community : physician and patient
perspective. Journal of Clinical Psychiatry 60 (Suppl. 7), 12–16.
Tylee, A. T., Freeling, P. & Kerry, S. (1993). Why do general
practitioners recognize major depression in one woman patient
1194 J. Nuyen et al.
yet miss it in another? British Journal of General Practice 43,
327–330.
Tylee, A., Freeling, P., Kerry, S. & Burns, T. (1995). How does the
content of consultations aﬀect the recognition by general prac-
titioners of major depression in women? British Journal of General
Practice 45, 575–578.
Westert, G. P., Schellevis, F. G., De Bakker, D. H., Groenewegen,
P. P., Bensing, J. M. & Van der Zee, J. (in press). Monitoring
health inequalities through General Practice : the Second Dutch
National Survey of General Practice. European Journal of Public
Health.
Whooley, M. A. & Simon, G. E. (2000). Managing depression in
medical outpatients. New England Journal of Medicine 343,
1942–1950.
Wittchen, H. U., Lieb, R., Wunderlich, U. & Schuster, P. (1999).
Comorbidity in primary care: presentation and consequences.
Journal of Clinical Psychiatry 60 (Suppl. 7), 29–36.
WONCA Classiﬁcation Committee (1983). International Classiﬁ-
cation of Health Problems in Primary Care (ICHPPC-2-Deﬁned).
Oxford University Press : Oxford.
WHO (1997). Composite International Diagnostic Interview – Version
2.1. World Health Organization: Geneva.
Diagnosing depression and co-morbidity 1195
